Cargando…

Expanding the clinical phenotype of IARS2-related mitochondrial disease

BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Vona, Barbara, Maroofian, Reza, Bellacchio, Emanuele, Najafi, Maryam, Thompson, Kyle, Alahmad, Ahmad, He, Langping, Ahangari, Najmeh, Rad, Abolfazl, Shahrokhzadeh, Sima, Bahena, Paulina, Mittag, Falk, Traub, Frank, Movaffagh, Jebrail, Amiri, Nafise, Doosti, Mohammad, Boostani, Reza, Shirzadeh, Ebrahim, Haaf, Thomas, Diodato, Daria, Schmidts, Miriam, Taylor, Robert W., Karimiani, Ehsan Ghayoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233262/
https://www.ncbi.nlm.nih.gov/pubmed/30419932
http://dx.doi.org/10.1186/s12881-018-0709-3
_version_ 1783370551676370944
author Vona, Barbara
Maroofian, Reza
Bellacchio, Emanuele
Najafi, Maryam
Thompson, Kyle
Alahmad, Ahmad
He, Langping
Ahangari, Najmeh
Rad, Abolfazl
Shahrokhzadeh, Sima
Bahena, Paulina
Mittag, Falk
Traub, Frank
Movaffagh, Jebrail
Amiri, Nafise
Doosti, Mohammad
Boostani, Reza
Shirzadeh, Ebrahim
Haaf, Thomas
Diodato, Daria
Schmidts, Miriam
Taylor, Robert W.
Karimiani, Ehsan Ghayoor
author_facet Vona, Barbara
Maroofian, Reza
Bellacchio, Emanuele
Najafi, Maryam
Thompson, Kyle
Alahmad, Ahmad
He, Langping
Ahangari, Najmeh
Rad, Abolfazl
Shahrokhzadeh, Sima
Bahena, Paulina
Mittag, Falk
Traub, Frank
Movaffagh, Jebrail
Amiri, Nafise
Doosti, Mohammad
Boostani, Reza
Shirzadeh, Ebrahim
Haaf, Thomas
Diodato, Daria
Schmidts, Miriam
Taylor, Robert W.
Karimiani, Ehsan Ghayoor
author_sort Vona, Barbara
collection PubMed
description BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies. METHODS: Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis. RESULTS: Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein. CONCLUSIONS: This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0709-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6233262
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62332622018-11-20 Expanding the clinical phenotype of IARS2-related mitochondrial disease Vona, Barbara Maroofian, Reza Bellacchio, Emanuele Najafi, Maryam Thompson, Kyle Alahmad, Ahmad He, Langping Ahangari, Najmeh Rad, Abolfazl Shahrokhzadeh, Sima Bahena, Paulina Mittag, Falk Traub, Frank Movaffagh, Jebrail Amiri, Nafise Doosti, Mohammad Boostani, Reza Shirzadeh, Ebrahim Haaf, Thomas Diodato, Daria Schmidts, Miriam Taylor, Robert W. Karimiani, Ehsan Ghayoor BMC Med Genet Research Article BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies. METHODS: Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis. RESULTS: Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein. CONCLUSIONS: This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0709-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-12 /pmc/articles/PMC6233262/ /pubmed/30419932 http://dx.doi.org/10.1186/s12881-018-0709-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Vona, Barbara
Maroofian, Reza
Bellacchio, Emanuele
Najafi, Maryam
Thompson, Kyle
Alahmad, Ahmad
He, Langping
Ahangari, Najmeh
Rad, Abolfazl
Shahrokhzadeh, Sima
Bahena, Paulina
Mittag, Falk
Traub, Frank
Movaffagh, Jebrail
Amiri, Nafise
Doosti, Mohammad
Boostani, Reza
Shirzadeh, Ebrahim
Haaf, Thomas
Diodato, Daria
Schmidts, Miriam
Taylor, Robert W.
Karimiani, Ehsan Ghayoor
Expanding the clinical phenotype of IARS2-related mitochondrial disease
title Expanding the clinical phenotype of IARS2-related mitochondrial disease
title_full Expanding the clinical phenotype of IARS2-related mitochondrial disease
title_fullStr Expanding the clinical phenotype of IARS2-related mitochondrial disease
title_full_unstemmed Expanding the clinical phenotype of IARS2-related mitochondrial disease
title_short Expanding the clinical phenotype of IARS2-related mitochondrial disease
title_sort expanding the clinical phenotype of iars2-related mitochondrial disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233262/
https://www.ncbi.nlm.nih.gov/pubmed/30419932
http://dx.doi.org/10.1186/s12881-018-0709-3
work_keys_str_mv AT vonabarbara expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT maroofianreza expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT bellacchioemanuele expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT najafimaryam expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT thompsonkyle expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT alahmadahmad expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT helangping expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT ahangarinajmeh expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT radabolfazl expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT shahrokhzadehsima expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT bahenapaulina expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT mittagfalk expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT traubfrank expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT movaffaghjebrail expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT amirinafise expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT doostimohammad expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT boostanireza expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT shirzadehebrahim expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT haafthomas expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT diodatodaria expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT schmidtsmiriam expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT taylorrobertw expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease
AT karimianiehsanghayoor expandingtheclinicalphenotypeofiars2relatedmitochondrialdisease